Nirmatrelvir/ritonavir for patients with SARS-CoV-2 infection and impaired kidney function during the Omicron surge

Background: Nirmatrelvir/ritonavir has demonstrated effectiveness in high-risk patients with coronavirus disease 2019 (COVID-19). However, investigations on the efficacy and safety of nirmatrelvir/ritonavir in patients with kidney dysfunction are limited. Methods: Data were collected from the patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Jiayi, Cai, Hong, Wang, Jieying, Zhu, Mingli, Li, Ping, Li, Peiying, Wu, Bin, Che, Xiajing, Gu, Leyi, Mou, Shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073454/
https://www.ncbi.nlm.nih.gov/pubmed/37033654
http://dx.doi.org/10.3389/fphar.2023.1147980

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073454/
https://www.ncbi.nlm.nih.gov/pubmed/37033654
http://dx.doi.org/10.3389/fphar.2023.1147980

Ejemplares similares